1278441

Martin Neil Reaume, MD — FEI 3015602595

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 25, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ottawa (Canada)

Additional Details

Clinical Investigator (CI)